# Cellectar Biosciences, Inc.: Form 8-K, filed Jun 25, 2024

- Company: [Cellectar Biosciences, Inc.](/companies/clrb.md) (CIK 1279704)
- Form: 8-K
- Filed: 2024-06-25
- Accepted by EDGAR: Jun 25, 2024, 16:09 ET
- Period: 2024-06-20
- Accession: 0001104659-24-074747
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1279704/000110465924074747/tm2418236d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1279704/000110465924074747/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1279704/000110465924074747/tm2418236d1_8k.htm

Filed Jun 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-074747. Last ingested by Listed: Nov 10, 2026, 16:55 ET. No prices; not investment advice.
